No Data
No Data
Atomwise Appoints Steve Worland, Ph.D. as Chief Executive Officer
Kaskela Law LLC Announces Investigation of EFFECTOR Therapeutics, Inc. (EFTR) and Encourages Former EFFECTOR Employees to Contact the Firm
Express News | EFFECTOR Therapeutics - Oxford Notice Indicates Obligations Under Loan and Security Agreement Shall Accrue Interest at Default Rate
Express News | EFFECTOR Therapeutics Inc - Oxford Notice Indicates That All Obligations Are Now Immediately Due and Payable
Express News | EFFECTOR Therapeutics- Got Notice From Oxford Finance, Events of Default Occurred With Respect to Loan,Security Agreement Dated as of March 19, 2021
EFFECTOR Therapeutics Declared in Default on $75M Oxford Finance Loan